Recent advances in the development of mutant-selective EGFR inhibitors for non-small cell lung cancer patients with EGFR-TKI resistance

Affiliation

• ¹ 1 Chest Medicine Division of Medicine Department, Fenglin branch, Taipei Veterans General Hospital, Taiwan ; 2 School of Medicine, National Yang-Ming Medical University, Taipei, Taiwan ; 3 Department of Chest Medicine, Taipei Veterans General Hospital, and 4 Taipei Cancer Center, College of Medical Science and Technology, Taipei Medical University, Taiwan, China.